Table of Contents
Advances in Pharmaceutics
Volume 2015, Article ID 154239, 10 pages
http://dx.doi.org/10.1155/2015/154239
Research Article

Enhanced Degradation of Lactide-co-Glycolide Polymer with Basic Nucleophilic Drugs

1Sunovion Pharmaceuticals Inc., Marlborough, MA 01752, USA
2Evonik Inc., 750 Lakeshore Parkway, Birmingham, AL 35211, USA
3Section of Pharmaceutical Chemistry, Department of Drug Sciences, University of Pavia, Viale Taramelli 12, 27100 Pavia, Italy
4University of Kentucky College of Pharmacy, Lexington, KY 40536, USA

Received 10 August 2014; Accepted 4 December 2014

Academic Editor: Mohammad F. Kiani

Copyright © 2015 Susan D’Souza et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. H. Kim, H. H. Jiang, C. W. Park et al., “PEGylated TNF-related apoptosis-inducing ligand (TRAIL)-loaded sustained release PLGA microspheres for enhanced stability and antitumor activity,” Journal of Controlled Release, vol. 150, no. 1, pp. 63–69, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. J. He, M. Feng, X. Zhou et al., “Stabilization and encapsulation of recombinant human erythropoietin into PLGA microspheres using human serum albumin as a stabilizer,” International Journal of Pharmaceutics, vol. 416, no. 1, pp. 69–76, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. N. Umeki, T. Sato, M. Harada et al., “Preparation and evaluation of biodegradable microspheres containing a new potent osteogenic compound and new synthetic polymers for sustained release,” International Journal of Pharmaceutics, vol. 392, no. 1-2, pp. 42–50, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. D. Bodmer, T. Kissel, and E. Traechslin, “Factors influencing the release of peptides and proteins from biodegradable parenteral depot systems,” Journal of Controlled Release, vol. 21, no. 1–3, pp. 129–137, 1992. View at Publisher · View at Google Scholar · View at Scopus
  5. P. P. DeLuca, R. C. Mehta, A. G. Hausberger, and B. C. Thanoo, “Biodegradable polyesters for drug and polypeptide delivery,” in Polymer Delivery Systems, Properties and Applications, ACS Symposium Series, American Chemical Society, Washington, DC, USA, 1993. View at Google Scholar
  6. S. D’Souza, J. Faraj, and P. Deluca, “Microsphere delivery of Risperidone as an alternative to combination therapy,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 85, no. 3, pp. 631–639, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Okada, Y. Doken, Y. Ogawa, and H. Toguchi, “Preparation of three-month depot injectable microspheres of leuprorelin acetate using biodegradable polymers,” Pharmaceutical Research, vol. 11, no. 8, pp. 1143–1147, 1994. View at Publisher · View at Google Scholar · View at Scopus
  8. G. Ploussard and P. Mongiat-Artus, “Triptorelin in the management of prostate cancer,” Future Oncology, vol. 9, no. 1, pp. 93–102, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. D. Fontana, M. Mari, A. Martinelli et al., “3-Month formulation of goserelin acetate (‘Zoladex’ 10.8-mg depot) in advanced prostate cancer: Results from an Italian, open, multicenter trial,” Urologia Internationalis, vol. 70, no. 4, pp. 316–320, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Sun, J. Wang, X. Zhang et al., “Synchronic release of two hormonal contraceptives for about one month from the PLGA microspheres: in vitro and in vivo studies,” Journal of Controlled Release, vol. 129, no. 3, pp. 192–199, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. B. H. Woo, J. W. Kostanski, S. Gebrekidan, B. A. Dani, B. C. Thanoo, and P. P. DeLuca, “Preparation, characterization and in vivo evaluation of 120-day poly(D,L-lactide) leuprolide microspheres,” Journal of Controlled Release, vol. 75, no. 3, pp. 307–315, 2001. View at Publisher · View at Google Scholar · View at Scopus
  12. H. V. Maulding, T. R. Tice, D. R. Cowsar, J. W. Fong, J. E. Pearson, and J. P. Nazareno, “Biodegradable microcapsules: acceleration of polymeric excipient hydrolytic rate by incorporation of a basic medicament,” Journal of Controlled Release, vol. 3, no. 1–4, pp. 103–117, 1986. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Cha and C. G. Pitt, “The acceleration of degradation-controlled drug delivery from polyester microspheres,” Journal of Controlled Release, vol. 8, no. 3, pp. 259–265, 1989. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Kishida, S. Yoshioka, S. Izumikawa, Y. Aso, and Y. Takeda, “Formulation-assisted biodegradable polymer matrices,” Chemical and Pharmaceutical Bulletin, vol. 37, pp. 1954–1956, 1989. View at Google Scholar
  15. R. Bodmeier and H. G. Chen, “Evaluation of biodegradable poly(lactide) pellets prepared by direct compression,” Journal of pharmaceutical sciences, vol. 78, no. 10, pp. 819–822, 1989. View at Publisher · View at Google Scholar · View at Scopus
  16. S. D’Souza, J. A. Faraj, S. Giovagnoli, and P. P. Deluca, “IVIVC from long acting olanzapine microspheres,” International Journal of Biomaterials, vol. 2014, Article ID 407065, 11 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Takada, T. Kurokawa, K. Miyazaki, S. Iwasa, and Y. Ogawa, “Sustained release of a water-soluble GP IIb/IIIa antagonist from copoly(d,l-lactic/glycolic)acid microspheres,” International Journal of Pharmaceutics, vol. 146, no. 2, pp. 147–157, 1997. View at Publisher · View at Google Scholar · View at Scopus
  18. S. J. Siegel, J. B. Kahn, K. Metzger, K. I. Winey, K. Werner, and N. Dan, “Effect of drug type on the degradation rate of PLGA matrices,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 64, no. 3, pp. 287–293, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Miyajima, A. Koshika, J. Okada, and M. Ikeda, “Effect of polymer/basic drug interactions on the two-stage diffusion-controlled release from a poly(L-lactic acid) matrix,” Journal of Controlled Release, vol. 61, no. 3, pp. 295–304, 1999. View at Publisher · View at Google Scholar · View at Scopus
  20. N. Wakiyama, K. Juni, and M. Nakano, “Preparation and evaluation in vitro of polylactic acid microspheres containing local anesthetics,” Chemical and Pharmaceutical Bulletin, vol. 29, no. 11, pp. 3363–3368, 1981. View at Publisher · View at Google Scholar · View at Scopus
  21. N. Wakiyama, K. Juni, and M. Nakano, “Influence of physicochemical properties of polylactic acid on the characteristics and in vitro release patterns of polylactic acid microspheres containing local anesthetics,” Chemical and Pharmaceutical Bulletin, vol. 30, no. 7, pp. 2621–2628, 1982. View at Publisher · View at Google Scholar · View at Scopus
  22. N. Wakiyama, K. Juni, and M. Nakano, “Preparation and evaluation in vitro and in vivo of polylactic acid microspheres containing dibucaine,” Chemical & Pharmaceutical Bulletin, vol. 30, no. 10, pp. 3719–3727, 1982. View at Publisher · View at Google Scholar · View at Scopus
  23. T. S. Harrison and K. L. Goa, “Long-acting Risperidone: a review of its use in Schizophrenia,” CNS Drugs, vol. 18, no. 2, pp. 113–132, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. H. He and J. S. Richardson, “A pharmacological, pharmacokinetic and clinical overview of risperidone, a new antipsychotic that blocks serotonin 5-HT2 and dopamine D2 receptors,” International Clinical Psychopharmacology, vol. 10, no. 1, pp. 19–30, 1995. View at Google Scholar · View at Scopus
  25. N. Bhana and C. M. Perry, “Olanzapine: a review of its use in the treatment of bipolar I disorder,” CNS Drugs, vol. 15, no. 11, pp. 871–904, 2001. View at Publisher · View at Google Scholar · View at Scopus
  26. P. L. McCormack and L. R. Wiseman, “Olanzapine: a review of its use in the management of bipolar I disorder,” Drugs, vol. 64, no. 23, pp. 2709–2726, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. S. D’Souza, J. A. Faraj, S. Giovagnoli, and P. P. DeLuca, “Preparation, characterization and in vivo evaluation of Olanzapine Poly(D,L-lactide-co-glycolide) (PLGA) microspheres,” Journal of Pharmaceutics, vol. 2013, Article ID 831381, 9 pages, 2013. View at Publisher · View at Google Scholar
  28. S. D’Souza, J. A. Faraj, S. Giovagnoli, and P. P. DeLuca, “Development of risperidone PLGA microspheres,” Journal of Drug Delivery, vol. 2014, Article ID 620464, 11 pages, 2014. View at Publisher · View at Google Scholar
  29. A. O. Eniola and D. A. Hammer, “Characterization of biodegradable drug delivery vehicles with the adhesive properties of leukocytes II: effect of degradation on targeting activity,” Biomaterials, vol. 26, no. 6, pp. 661–670, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Ramstack, G. Grandolfi, and E. Mannaert, “Long-acting Risperidone: prolonged release injectable delivery of Risperidone using Medisorb microsphere technology,” Biological Psychiatry, vol. 53, abstract 547, 2003. View at Google Scholar
  31. S. S. D’Souza, J. A. Faraj, and P. P. DeLuca, “A model-dependent approach to correlate accelerated with real-time release from biodegradable microspheres,” AAPS PharmSciTech, vol. 6, no. 4, article no. 70, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. B. Buchholz, “Accelerated degradation test on resorbable polymers,” in Degradation Phenomena of Polymeric Biomaterials, p. 67, Springer, New York, NY, USA, 1992. View at Google Scholar
  33. J. E. Bergsma, F. R. Rozema, R. R. M. Bos, G. Boering, C. A. P. Joziasse, and A. J. Pennings, “In vitro predegradation at elevated temperatures of poly(lactide),” Journal of Materials Science: Materials in Medicine, vol. 6, no. 11, pp. 642–646, 1995. View at Publisher · View at Google Scholar · View at Scopus
  34. C. M. Agrawal, D. Huang, J. P. Schmitz, and K. A. Athanasiou, “Elevated temperature degradation of a 50:50 copolymer of PLA-PGA,” Tissue Engineering, vol. 3, no. 4, pp. 345–352, 1997. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Shameem, H. Lee, and P. P. DeLuca, “A short-term (accelerated release) approach to evaluate peptide release from PLGA depot formulations,” AAPS PharmSci, vol. 1, no. 3, article 7, 1999. View at Google Scholar · View at Scopus
  36. S. D’Souza, J. A. Faraj, R. Dorati, and P. P. DeLuca, “A short term quality control tool for biodegradable microspheres,” AAPS PharmSciTech, vol. 15, no. 3, pp. 530–541, 2014. View at Publisher · View at Google Scholar · View at Scopus